<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Infectious%20Diseases/Antimicrobial%20Resistant%20Gram-Negative%20Infections/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Antimicrobial Resistant Gram-Negative Infections - MedNotes</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Antimicrobial Resistant Gram-Negative Infections", url: "#_top", children: [
          ]},
          {title: "ESBL-E", url: "#esbl-e", children: [
          ]},
          {title: "Antibiotic Dosing", url: "#antibiotic-dosing", children: [
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Babesiosis/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Babesiosis/" class="btn btn-xs btn-link">
        Babesiosis
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Antibiotics%20101/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Antibiotics%20101/" class="btn btn-xs btn-link">
        Antibiotics 101
      </a>
    </div>
    
  </div>

    

    <h1 id="antimicrobial-resistant-gram-negative-infections">Antimicrobial Resistant Gram-Negative Infections</h1>
<p><strong>Guideline Reference:</strong> <a href="https://www.idsociety.org/practice-guideline/amr-guidance/#Extended-Spectrum%CE%B2-Lactamase-ProducingEnterobacterales">IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections</a> (July 18, 2023)</p>
<p><strong>Guideline Scope:</strong> This guideline focuses on ESBL Enterobacterales, AmpC ESBL, CPE, MDR Pseudomonas, Carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia.</p>
<h1 id="esbl-e">ESBL-E</h1>
<p>ESBLs are enzymes that inactivate most penicillins, cephalosporins, and aztreonam. EBSL-E generally remain susceptible to carbapenems. ESBLs do not inactivate non–β-lactam agents (eg, ciprofloxacin, trimethoprim-sulfamethoxazole, gentamicin). However, organisms carrying ESBL genes often harbor additional genes or mutations in genes that mediate resistance to a broad range of antibiotics.</p>
<p>ESBL-Enterobacterales is growing in community prevalence in the USA. Any gram-negative organism has the potential to harbor ESBL genes; however, they are most prevalent in <em>Escherichia coli</em>, <em>Klebsiella pneumoniae</em>, <em>Klebsiella oxytoca</em>, and <em>Proteus mirabilis</em>.</p>
<table>
<thead>
<tr>
<th>Infection</th>
<th>Recommended Regimen</th>
</tr>
</thead>
<tbody>
<tr>
<td>Uncomplicated Cystitis</td>
<td><strong>Nitrofurantoin, TMPSMX.</strong> Less preferred are cipro, levoflox, and carbapenems. Single dose aminoglycosides and oral fosfomycin are also alternatives.</td>
</tr>
<tr>
<td>Pyelonephritis and complicated UTI</td>
<td><strong>TMP-SMX, ciprofloxacin, or levofloxacin</strong> are preferred treatment options. Ertapenem, meropenem, imipenem are second-line. Aminoglycosides for a full treatment course are an alternative. Fosfomycin and nitrofurantoin do not achieve adequate concentrations in the renal parenchyma and are therefore not recommended.</td>
</tr>
<tr>
<td></td>
<td></td>
</tr>
</tbody>
</table>
<h1 id="antibiotic-dosing">Antibiotic Dosing</h1>
<p><a href="https://www.idsociety.org/globalassets/idsa/practice-guidelines/amr-guidance/1.0/idsa-amr-guidance-v3.0.pdf#page=6"><img alt="" src="https://www.idsociety.org/globalassets/idsa/practice-guidelines/amr-guidance/1.0/table-1.png" /></a></p>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Babesiosis/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Babesiosis/" class="btn btn-xs btn-link">
        Babesiosis
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Antibiotics%20101/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Antibiotics%20101/" class="btn btn-xs btn-link">
        Antibiotics 101
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>